San Francisco, CA – May 19, 2021 — Helo Corp. (OTC: HLOC) (“Helo” or the “Company), a leading developer of wearable wireless devices and bio-data informed personalized products and services, dedicated to improving wellness worldwide, is pleased to announce its full year 2020 audited results and alternative filing with OTC Markets.
- Revenue for the full year ended December 31, 2020 increased by $15.2 million, or 760%, to $17.2 million, from $2.0 million for the year ended December 31, 2019. The increase in revenue was primarily due to the launch of its second-generation products, expanded product range and change of its business model from September 1, 2020.
- Gross profit for the full year ended December 31, 2020 increased by $4.7 million, or 1175%, to $5.2 million, from $0.4 million for the year ended December 31, 2019.
- Gross margin for the full year ended December 31, 2020 increased by 80 basis points to 29%, from 21% for the year ended December 31, 2019.
- Operating income for the full year ended December 31, 2020 increased $2.6 million to $1.5 million, from an operating loss of $1.1 million for the year ended December 31, 2019.
- Net income for the full year ended December 31, 2020 increased $2.9 million to $1.3 million, from a net loss of $1.6 million for the year ended December 31, 2019.
- The resulting positive EPS for the full year ended December 31, 2020 was $0.04, as compared to a negative EPS of ($0.04) for the year ended December 31, 2019.
Seán McVeigh, Helo’s Chief Executive Officer, commented, “2020 was a significant year for us as we launched our second-generation devices and took action to capture more of our downstream value chain. In September, 2020 increased our range of products and services and we moved away from our traditional wholesale business model. We opened our consumer e-commerce portal and used it to convert customer referrals to sales. As seen by the upswing in the last quarter of 2020, these changes have set the stage for accelerated growth and profitability for 2021 and years to come.”
Fabio Galdi, Vyvo’s Chief Executive Office, stated, “Our patented technology, recurring revenue from our digital reports and NutraPak™ sales, combined with our leadership in the Digital Health Sharing economy where our Vyvo wearers get paid for their data, ensures that we will achieve our strategic goal to build a growing community of loyal customers in the wellness market. Galdi continued, “We look forward to opening up our Digital Health Sharing economy to new partners who seek to access our anonymized bio-metric database and bring further value to our Vyvo members”.
Helo Corp launched its second-generation products and new products in 2020:
Watch Lite – Launched January, 2020, Watch Lite is an “Ultra-thin” (7mm thick) Life Watch with data collection capabilities that enable features such as continuous atrial fibrillation detection, mood and energy monitoring, fall detection, blood oxygenation measurement capability and sleep apnea detection.
Watch Lite Special Edition – is a Watch Lite with the addition of a Texas Instruments high precision, medical-grade digital temperature sensor capable of providing body temperature readings with an accuracy of up to ±0.1°C, complying with the ASTM E1112 and ISO 80601-2-56 standards. The first Watch Lite Special Edition was shipped in June 2020.
Watch Generation 2 – is the Company’s flagship Life Watch, with its US patent pending fingertip side sensor enabling high quality measurements such as Blood Pressure and blood oxygenation, together with the complete suite of sensors and services offered by Vyvo. The first Watch 2 was shipped by the Company in September 2020. For an overview of Vyvo’s Life Watch Generation 2, please click on the icon[1].
NutraPak™ and Digital Services
From September 1, 2020, the Company changed its business model to sell to wellness consumers its generation 2 devices and additional products. These include NutraPak™, a continuously updated, personalized, customer specific easy-melt supplement which we deliver to our customer’s door and a range of Oracle AI personalized services which are delivered electronically. All of our new products and services are enabled using our customer (and VyvoPay™ rewarded) updated data, gathered by Vyvo™ devices worn by our customers worldwide.
About Helo Corp.
Helo Corp. (OTC: HLOC) is a wellness technology company at the forefront of the digital health sharing economy, using life watches and its proprietary bio-metrics data platform to encourage wellness-centered lifestyles and enabling consumer data empowerment under the Vyvo™ brand. Our Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided, data rich platform collects health data from the users which we analyze and use AI to formulate customized and personalized user reports, user alerts and Nutrapak™ supplements, and our platform also presents Big Data opportunity for developers, medical research, and diagnostics.
For further information on Vyvo and Helo, please click on the links below:
https://www.vyvo.com and http://www.helocorp.com
Join Vyvo’s Facebook Community: https://www.facebook.com/VyvoCorp
Forward Looking Statement
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
Investors Contact:
investors@helocorp.com
650-646-2193
ClearThink
Brian Loper
(347) 413-4234
[1] https://vimeo.com/469087851